|
|
|
|
| LEADER |
00000nz a2200000n 4500 |
| 001 |
1893098311 |
| 003 |
DE-627 |
| 005 |
20240702212754.0 |
| 008 |
240702n||aznnnabbn | aaa |c |
| 024 |
7 |
|
|a http://d-nb.info/gnd/1334636702
|2 uri
|
| 035 |
|
|
|a (DE-588)1334636702
|
| 035 |
|
|
|a (DE-627)1893098311
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 043 |
|
|
|c XD-US
|
| 079 |
|
|
|a g
|b p
|c v
|q f
|v piz
|
| 100 |
1 |
|
|a Bloswick, Agata
|
| 510 |
2 |
|
|0 (DE-627)656847670
|0 (DE-576)341103047
|0 (DE-588)16153517-3
|a Laboratory Corporation of America Holdings
|g Burlington, NC
|4 affi
|w r
|i Affiliation
|e Affiliation
|
| 548 |
|
|
|a 2022-
|4 datw
|w r
|i Wirkungsdaten
|
| 550 |
|
|
|0 (DE-627)604403216
|0 (DE-576)308339541
|0 (DE-588)7664670-1
|a Geschäftsführerin
|4 berc
|w r
|i Charakteristischer Beruf
|
| 550 |
|
|
|0 (DE-627)104585234
|0 (DE-576)208867074
|0 (DE-588)4006791-9
|a Bioethik
|4 them
|w r
|i Thema
|
| 678 |
|
|
|b Geschäftsführende Direktorin und globale Leiterin der Start-up-Aktivitäten für das operative Segment der Arzneimittelentwicklung der Laboratory Corporation of America Holdings (2022)
|
| 692 |
|
|
|a Facilitating Ukrainian Refugees’ Continued Participation in Clinical Trials
|
| ORI |
|
|
|a SA-MARC-ixtheoc001.raw
|
| SUB |
|
|
|a IXT
|b 1
|
| TIT |
|
|
|a ixtheo
|
GND (1334636702)
Prometheus (1334636702)